Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.
13h
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially ...
Go out at night when the sky is clear and take a look around more often than not, you'll see fewer stars than your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results